Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 212 of 1,261
  1. CA 3217274

    PROCEDE DE FABRICATION D'UNE SOLUTION D'UN COMPLEXE DE GADOLINIUM

    BRACCO IMAGING SPA [IT] · Granted Feb 2, 2023 · Expires Jan 28, 2043

    granted
  2. US 11566263

    Compositions and methods for treating CEP290 associated disease

    Editas Medicine, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  3. US 11565096

    Delivery system for a pharmaceutical, holistic or medicinal component

    Herphoric, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  4. US 11567073

    Receptor tyrosine kinase biomarkers

    United Kingdom Research and Innovation · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  5. US 11565027

    Hydrogel membrane for adhesion prevention

    The Board of Regents of the University of Texas System · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  6. US 11564954

    Tumor-delivered multi-target therapeutics for colon cancer

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  7. US 11564914

    Methods of treating bone loss

    The Regents of the University of California · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  8. US 11566224

    Dendritic cell generator

    Northwestern University · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  9. US 11566228

    Hemangio-colony forming cells

    Astellas Institute for Regenerative Medicine · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  10. US 11566011

    Highly purified pharmaceutical grade tasimelteon

    VANDA PHARMACEUTICALS INC. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  11. US 11566230

    Universal donor cells

    CRISPR THERAPEUTICS AG · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  12. US 11566015

    Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  13. US 11566041

    Nucleotide prodrug compounds

    Ligand Pharmaceuticals Incorporated · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  14. US 11565001

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  15. US 11565107

    Tolerable and minimally invasive skin electroporation device

    Inovio Pharmaceuticals, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  16. US 11564997

    Materials and methods for treatment of friedreich ataxia and other related disorders

    CRISPR THERAPEUTICS AG · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  17. US 11564949

    Ameliorating nervous systems disorders

    The Regents of the University of California · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  18. US 11566253

    Targeted gene demethylation in plants

    The Regents of the University of California · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  19. US 11564981

    Vaccine for prevention of necrotic enteritis in poultry

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  20. US 11564927

    Therapeutic compositions, combinations, and methods of use

    VERASTEM, INC. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  21. US 11564916

    Pharmaceutical composition and administrations thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  22. US 11564891

    Chloroquine gel and preparation method and application thereof

    GUANGZHOU HYBRIBIO BIOTECH LTD. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  23. US 11566242

    Methods and compositions for reprogramming cells

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  24. US 11565000

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.